Pinnacle Associates LTD Prothena Corp Public LTD CO Transaction History
Pinnacle Associates LTD
- $7.08 Billion
- Q4 2024
A detailed history of Pinnacle Associates LTD transactions in Prothena Corp Public LTD CO stock. As of the latest transaction made, Pinnacle Associates LTD holds 103,081 shares of PRTA stock, worth $948,345. This represents 0.02% of its overall portfolio holdings.
Number of Shares
103,081
Previous 125,747
18.03%
Holding current value
$948,345
Previous $2.1 Million
32.14%
% of portfolio
0.02%
Previous 0.03%
Shares
32 transactions
Others Institutions Holding PRTA
# of Institutions
197Shares Held
39.4MCall Options Held
601KPut Options Held
259K-
Eco R1 Capital, LLC San Francisco, CA11.6MShares$107 Million7.5% of portfolio
-
Black Rock Inc. New York, NY3.86MShares$35.5 Million0.0% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD3.69MShares$33.9 Million0.01% of portfolio
-
Armistice Capital, LLC New York, NY2.24MShares$20.6 Million0.44% of portfolio
-
State Street Corp Boston, MA1.86MShares$17.1 Million0.0% of portfolio
About PROTHENA CORP PUBLIC LTD CO
- Ticker PRTA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 46,922,800
- Market Cap $432M
- Description
- Prothena Corporation plc, a late-stage clinical company, focuses on discovery and development of novel therapies for life-threatening diseases in the United States. The company is involved in developing Birtamimab, an investigational humanized antibody that is in Phase III clinical trial for the treatment of AL amyloidosis; Prasinezumab, a human...